載入...
CMET-03. PHASE 1 TRIAL OF OSIMERTINIB WITH STEREOTACTIC RADIOSURGERY IN EGFR MUTANT LUNG CANCER BRAIN METASTASIS
BACKGROUND: Brain metastases (BM) occurs in 25–40% of patients with non-small cell lung cancer (NSCLC). Traditionally patients with brain metastases were treated with whole brain radiation therapy (WBRT), stereotactic radiosurgery (SRS) and surgical resection. Historically, BM is associated with dis...
Na minha lista:
發表在: | Neuro Oncol |
---|---|
Main Authors: | , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Oxford University Press
2018
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216839/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.216 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|